BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 33.3% in September

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totalling 1,200 shares, a decrease of 33.3% from the August 31st total of 1,800 shares. Based on an average daily volume of 600 shares, the days-to-cover ratio is presently 2.0 days.

BioSyent Stock Performance

BioSyent stock remained flat at $8.19 during trading hours on Friday. The company’s stock had a trading volume of 294 shares, compared to its average volume of 2,153. BioSyent has a 12 month low of $5.65 and a 12 month high of $8.56. The firm has a fifty day simple moving average of $7.65 and a two-hundred day simple moving average of $7.03.

BioSyent Increases Dividend

The company also recently disclosed a dividend, which was paid on Sunday, September 15th. Stockholders of record on Thursday, September 5th were paid a $0.0334 dividend. This is a positive change from BioSyent’s previous dividend of $0.03. This represents a dividend yield of 1.72%. The ex-dividend date was Wednesday, September 4th.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.